0 Comments
0 Shares
782 Views
0 Reviews
Search
Discover new people, create new connections and make new friends
-
Please log in to like, share and comment!
-
Molecular Diagnostics Market Future Business Opportunities, Revenue Streams and Forecast to 2033Molecular Diagnostics Market Synopsis 2025: New York, United States, The purpose of this section's research is to study the Molecular Diagnostics Market during the course of the estimated period using several confirmed parameters based on Porter's Five Forces Model. As a result, a thorough inspection of the market helps in recognizing and emphasizing the market's crucial strengths and...0 Comments 0 Shares 749 Views 0 Reviews
-
Molecular Diagnostics Market to Reach USD 36.53 Billion by 2033 Driven by Precision Healthcare DemandThe global Molecular Diagnostics Market is experiencing significant growth as healthcare systems increasingly adopt advanced diagnostic technologies for accurate and early disease detection. According to Straits Research, the market was valued at USD 15.78 billion in 2024 and is projected to grow from USD 17.55 billion in 2025 to USD 36.53 billion by 2033, registering a CAGR of 9.36% during the...0 Comments 0 Shares 470 Views 0 Reviews
-
Strategic Developments Accelerating the China Point of Care Molecular Diagnostics MarketThe demand for the China Point of Care Molecular Diagnostics Market is accelerating rapidly, driven by an urgent need for timely and accurate diagnostic solutions. As the market is set to expand from USD 432.75 million today to USD 1,124.1 million by 2035, with a CAGR of 8.28%, various factors are propelling this growth. This surge is largely attributable to rising healthcare expenditure and...0 Comments 0 Shares 105 Views 0 Reviews
-
Biological Agent Detection Device Market Forecasted Growing 9.7% CAGR Until-2034According to a new report from Intel Market Research, the global Biological Agent Detection (PCR, Immunoassay) Device market was valued at USD 4.4 billion in 2025 and is projected to reach USD 9.9 billion by 2034, growing at a robust CAGR of 9.7% during the forecast period (2026–2034). This growth is propelled by rising global investments in biodefense programs, heightened concern over...0 Comments 0 Shares 1K Views 0 Reviews